GlobeNewswire 4/30/2018 Guillain-Barré Syndrome Market to reach value of US$ 708.6 Mn by 2025, Says TMR
GlobeNewswire 4/30/2018 Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance For 2018
GlobeNewswire 4/24/2018 ADMA Biologics Announces the Release of its First Commercial Batch of Nabi-HB Manufactured Under its...
GlobeNewswire 4/13/2018 Paratek Appoints Rolf K. Hoffman to Company’s Board of Directors
GlobeNewswire 4/6/2018 Global Antibody Drug Conjugate Drug Sales, Pipeline Analysis & Market Forecasts 2018-2023
GlobeNewswire 3/5/2018 ADMA Biologics Reports Full Year 2017 Financial Results
GlobeNewswire 12/6/2017 Non-Antibody Protein Scaffolds Drugs and Diagnostics Market, 2030
GlobeNewswire 11/16/2017 Antibody Drug Conjugates Market, 2030 - Market is Anticipated to Grow at a CAGR to 19.4%
GlobeNewswire 11/16/2017 Curetis Publishes Business and Financial Update for the First Nine Months of 2017
GlobeNewswire 11/13/2017 ADMA Biologics Announces Closing of $42M Follow-On Offering
GlobeNewswire 11/9/2017 ADMA Biologics Announces Pricing of Follow-On Offering
GlobeNewswire 11/3/2017 ADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial Results
GlobeNewswire 10/18/2017 Global Markets for Blood Plasma Products, 2015-2017 & 2021
GlobeNewswire 10/11/2017 Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing
GlobeNewswire 8/23/2017 ADMA Biologics to Present at Upcoming Investor Conferences
GlobeNewswire 8/16/2017 Curetis Announces Financial Results for the First Six Months of 2017
GlobeNewswire 8/15/2017 Curetis Partners with Biotest to support academic PEPPER Pentaglobin® Peritonitis Trial with Unyvero...
GlobeNewswire 8/11/2017 ADMA Biologics Provides Corporate Update and Reports Second Quarter 2017 Financial Results
GlobeNewswire 7/31/2017 ADMA Biologics Strengthens Patent Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic M...
GlobeNewswire 7/6/2017 Biopharmaceutical Contract Manufacturing Market, 2027
GlobeNewswire 6/27/2017 ADMA Biologics Provides Corporate Timeline and Activities Update to Stockholders
GlobeNewswire 6/22/2017 $11.24 Billion Glucose Monitoring Market, 2023
GlobeNewswire 6/6/2017 ADMA Biologics Completes Acquisition of Biotest’s Therapy Business Unit Assets
GlobeNewswire 5/30/2017 ADMA Biologics Stockholders Vote to Approve Acquisition of Certain Assets from Biotest Pharmaceutica...
GlobeNewswire 5/25/2017 ADMA Biologics to Present at Jefferies 2017 Healthcare Conference